Dr. Reddy’s launches Semaglutide tablets in India
Dr. Reddy's Laboratories has launched in India oral semaglutide biosimilar in tablet form. The product will be available under Obeda brand, the same name under which the Hyderabad-based generic drugmaker had rolled out the generic version of the type 2 diabetes drug in injection form on March 21. The launch in tablet form comes days after it introduced its generic…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
